HCA Healthcare, Inc. (HCA) Stock: Price, Forecast & Analyst Target
HCA Healthcare, Inc. (HCA) — MoonshotScore 77/100 (Strong band), calculated Nov 18, 2026. Price $476.35 (-4.96%), as of the Nov 18, 2026 trading session; market cap $99.5B. Expected results Jan 26, 2027.
Educational signal · not a buy or sell recommendation · How to read this
HCA Healthcare, Inc. · HCA · NYSE · Healthcare · Medical - Care Facilities
Research dated 2026-09-12: HCA Healthcare delivers hospital and outpatient care across a broad clinical network, collecting revenue from commercial insurers and government programs rather than selling insurance itself. Patient activity and outpatient expansion must keep lifting operating profit while a debt-heavy capital structure limits tolerance for execution setbacks.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · HCA Healthcare (HCA)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and durable growth, though the balance sheet is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Compounding; Momentum: Surging.
- EPS beat 0 of the last 4 reports
- expected results Jan 26, 2027
- Altman Z 2.56 · Piotroski F 6
Helping: business quality, an attractive price, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 73 | Strong | |
| 80 | Exceptional | |
| 80 | Exceptional | |
| 80 | Exceptional | |
| 77 | Strong | |
| 77 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $476.35 | |
| Change on the day | -4.96% | |
| 52-week range | $353.99–$556.52 | |
| Market capitalisation | $99.5B | — |
| Price / earnings (trailing) | 16.56 | |
| Shares traded on the day | 1.60M | |
| Beta (volatility vs the S&P 500) | 1.11 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for HCA Healthcare (HCA): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is HCA Healthcare (HCA), and what does it report?
Short answer · as of
HCA is a care-delivery network spanning acute hospitals, emergency care, surgery, imaging, rehabilitation, oncology, physician practices and psychiatric treatment.
Research dated 2026-09-12.
Its revenue measures care funded through distinct payer channels, with managed care and other insurers forming the largest category and managed Medicare also carrying substantial weight.
Annual revenue advanced throughout the displayed history. Net income recovered from its trough as revenue continued rising, showing that the earnings path depends on how efficiently additional care volume passes through the network.
What do the latest results show for HCA Healthcare (HCA)?
Research dated 2026-09-12.
The latest period produced the highest quarterly revenue in the displayed series, while operating profit and net income improved from the immediately preceding period. Reported revenue and earnings also exceeded market estimates, continuing a run of earnings outcomes above expectations.
Those are reported outcomes. Management separately attributes prospective operating leverage to volume growth and says its resilience initiatives should improve cost trends, while the cash-flow record shows that operating cash generation remains positive but variable.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $19.85B Oct 27, 2026
- Latest report · revenue estimate
- $19.33B Oct 27, 2026
- Latest report · revenue vs estimate
- Above estimate Oct 27, 2026
- Latest report · EPS vs estimate
- Above estimate Oct 27, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Oct 27, 2026 | $19.85B | $19.33B | $7.2200 | $6.6500 |
| Jul 24, 2026 | $20.23B | $19.76B | $7.5900 | $7.5600 |
| Apr 24, 2026 | $19.11B | $19.09B | $7.1500 | $7.1200 |
| Jan 27, 2026 | $19.51B | $19.68B | $8.0100 | $7.4600 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $19.16B | $1.64B | $6.96 (diluted) |
| Q4 FY2025 | $19.51B | $1.88B | $8.14 (diluted) |
| Q1 FY2026 | $19.11B | $1.62B | $7.15 (diluted) |
| Q2 FY2026 | $20.23B | $1.70B | $7.62 (diluted) |
What are the financial strengths and risks for HCA Healthcare (HCA)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
Operations consistently generated cash across the displayed periods, and cash remaining after capital expenditure stayed positive despite heavy investment in facilities. That cash engine is the principal financial support for a network requiring persistent capital spending.
Debt towers over cash and investments, while short-term liquidity ratios remain below full coverage. The cash reserve also declined sharply across the reported window, even though recent balances have been comparatively stable; positive operating cash flow therefore has not translated into cash accumulation.
Payer economics and cost control meet directly in HCA’s margins. Weaker reimbursement or renewed cost pressure would become more consequential if operating cash conversion slipped while debt and capital requirements remained elevated.
What should you watch next at HCA Healthcare (HCA)?
Short answer · as of
The next earnings report is expected on Jan 26, 2027.
Research dated 2026-09-12.
The scheduled earnings release should be tested against the recent revenue peak, the sequential improvement in operating profit and the durability of cash remaining after capital expenditure. The important observation is not merely whether estimates are cleared, but whether revenue growth continues to produce operating leverage.
Management has linked its growth agenda to a large pipeline of outpatient facilities and its margin outlook to better cost trends. Confirmation would come from sustained volume-led profit growth without renewed cash erosion; deterioration would appear as costs outrunning revenue while capital spending and debt remain heavy.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does HCA Healthcare compare with its peers?
Short answer
HCA Healthcare's score ranks 11th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
HCA should not be read as merely an acute-hospital chain. Its network reaches across hospital care, freestanding emergency and surgery sites, urgent care, diagnostics, rehabilitation, oncology, physician practices and behavioral health, making outpatient expansion a core growth route rather than an incidental service.
The economic reporting lens is payer-based rather than facility-based: managed care and other insurers dominate revenue, alongside managed Medicare, traditional Medicare and Medicaid channels. Comparisons based only on hospital capacity can therefore miss the payer mix that converts clinical activity into revenue.
| Company | Price | Market value | Score |
|---|---|---|---|
| $271.34 Nov 18, 2026 | $21.6B | 94 5-pillar Nov 18, 2026 | |
| $13.77 Nov 18, 2026 | $5.24B | 92 5-pillar Nov 18, 2026 | |
| $186.07 Nov 18, 2026 | $10.7B | 91 5-pillar Nov 18, 2026 | |
| $536.45 Nov 18, 2026 | $136B | 90 5-pillar Nov 18, 2026 | |
| $47.12 Nov 18, 2026 | $113B | 87 5-pillar Nov 18, 2026 | |
| $59.56 Nov 18, 2026 | $122B | 85 5-pillar Nov 18, 2026 | |
| $546.72 Nov 18, 2026 | $7.09B | 85 5-pillar Nov 18, 2026 | |
| $81.34 Nov 18, 2026 | $104B | 81 5-pillar Nov 18, 2026 | |
| $134.94 Nov 18, 2026 | $13.2B | 81 5-pillar Nov 18, 2026 | |
| $20.95 Nov 18, 2026 | $10.9B | 80 5-pillar Nov 18, 2026 | |
| HCA Healthcare (HCA) — this page | $476.35 | $99.5B | 77 |
| $161.75 Nov 18, 2026 | $10.2B | 76 5-pillar Nov 18, 2026 | |
| $182.98 Nov 18, 2026 | $10.7B | 74 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $369.00 – $579.00
- Consensus target
- $466.26
- Median target
- $485.00
Consensus record · Captured .
Measured against a quoted price of $476.35 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 10, 2026
- Transactions
- 35
- Identified insiders
- 7
- Purchases
- 0
- Sales
- 10
- Other transactions
- 25
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held HCA in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0.38% | $86.26M | Trimmed −0.5% shares |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about HCA Healthcare (HCA)?
Common Questions About HCA (Healthcare)
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How does HCA earn revenue from managed care patients?
HCA provides clinical services through hospitals and outpatient facilities, while managed-care organizations and other insurers fund the largest reported revenue category. Revenue therefore depends on care activity and the economics attached to the payer channel.
What does HCA’s outpatient expansion change about its hospital-centered model?
The expansion adds more entry points for surgery, emergency care, diagnostics, rehabilitation and physician services beyond the hospital campus. Management’s facility pipeline makes these settings a material route for extending the care network.
Why can HCA generate cash while its cash reserve declines?
Operating cash flow has remained positive and has exceeded capital expenditure throughout the displayed periods, yet the cash balance fell materially across the broader window. Cash generation from operations therefore does not describe every use of capital affecting the reserve.
Did HCA’s latest revenue gain strengthen operating profit?
Quarterly revenue reached the high point of the displayed series, and operating profit improved from the preceding period. Management says volume growth created operating leverage, while continued cost improvement remains an execution test.
What is the HCA stock price today?
The last price recorded for HCA Healthcare, Inc. (HCA), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the HCA price target?
The analyst consensus price target for HCA Healthcare, Inc. (HCA), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 41 figures on this page — 1 from SEC filings and earnings calls, 34 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold HCA
Funds in our ETF coverage that list HCA among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| SMI 3Fourteen Full-Cycle Trend ETF (FCTE) | 5.39% | |
| IHF ETF | 5.28% | |
| FLDZ ETF | 0.51% |